Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.
from WebMD Health https://ift.tt/CmFYrP6
Study results show semaglutide for weight loss (Wegovy) cut problems in the heart and blood vessels in a 17,000-person trial, which should reframe the health benefit of this weight loss drug.
0 comments:
Post a Comment